US & HILT Comparative Effect on Neuropathic Pain, Strength & QOF in Diabetic Foot
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jun 24, 2024
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different treatments—therapeutic ultrasound and high-intensity laser therapy—to see how they help with pain, strength, and overall quality of life for patients suffering from diabetic foot issues. The study focuses on people with type 2 diabetes who have been living with nerve pain in their legs or feet for at least six months. The goal is to find out which of these treatments works better for relieving pain and improving daily functioning.
To participate in this trial, you need to be between 50 and 75 years old and have been diagnosed with diabetes for at least seven years. Both men and women are welcome to join, but certain conditions, like being pregnant or having had major surgeries on your back or legs, would exclude you. If you decide to participate, you can expect to receive one of the two therapies and be monitored for changes in your pain, strength, and quality of life during the study. This trial is currently recruiting participants, so it's a great opportunity to explore new treatment options for diabetic foot pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with type 2 diabetes.
- • Diabetic Patients of age 50 to 75 years.
- • Diabetic patient of Both genders
- • Diagnosed Diabetes Mellitus with at least 7 years of duration
- • Distal symmetrical or asymmetrical polyneuropathy with pain in the lower extremity for ≥6 months
- • DNS (Diabetic neuropathy symptoms questionnaire) score greater than 4 (90 percent probability of neuropath
- Exclusion Criteria:
- • Pregnant females
- • Lower limb Amputated patients
- • History or evidence of neurological disorders other than peripheral neuropathy associated with Diabetes mellitus.
- • Evidence of musculoskeletal dysfunctions like scoliosis, lumbar disc prolapses and lumbar spine associated radiculopathy.
- • History of any low back surgeries and lower limb surgeries
- • Patient with malignancy. Patient with epilepsy
- • Patient with hemophilia
- • Patient with pacemaker, metal implants prosthesis and internal fixation screws.
- • Patient with severe cervical and lumbar neuropathy, rheumatoid arthritis, hereditary neuropathy
- • Patient with a history of neurosurgery
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bahawalpur, Punjab, Pakistan
Patients applied
Trial Officials
Aruba Saeed, Phd
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported